Citations

Clear

13 citation(s) found for "Johnson, Kimberly".

Paid Sick Leave, Care Delays, and Mortality Risk in Working Cancer Survivors
Kohut-Jackson, Abigail , Chino, Fumiko , Zheng, Zhiyuan , Han, Xuesong , Johnson, Kimberly , Yabroff, K. Robin , Johnston, Kenton J. , Barnes, Justin M. , Johnson, Kimberly J , Johnston, Kenton , Han, Xuesong , Yabroff, K Robin

Mayo Clinic

JCO Oncology Practice | June 10, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1200/op-26-00261 | PMID 42269119 Get It

PURPOSE Cancer survivors endure costly and time-intensive care throughout treatment and survivorship. Paid sick leave provides employment and financial stability while supporting time off for medical needs. We investigated whether paid sick leave is associated with financial hardship and overall and cancer-specific mortality risk in working adult cancer survivors. METHODS Working adults age 18-64 years with a cancer history were identified from the National Health Interview Survey (NHIS) between 2011 and 2023. Associations of paid sick leave and financial hardship (medical care delays, problems paying medical bills, worry about paying medical bills, and cost-related medication underuse) were examined with 2011-2018 and 2019-2023 data using separate multivariable logistic regressions because of survey redesign in 2019. Linked mortality files from the National Death Index were available for 2011-2018 respondents. The association of paid sick leave and mortality risk was examined with multivariable Cox proportional hazards models. RESULTS A total of 8,091 and 3,919 working cancer survivors were identified from the 2011-2018 and 2019-2023 NHIS, respectively. Paid sick leave was associated with decreased medical care delays because of cost (2011-2018 odds ratio [OR], 0.74 [95% CI, 0.60 to 0.93]; P = .008; 2019-2023 OR, 0.51 [95% CI, 0.35 to 0.74]; P < .001) but not consistently with other forms of financial hardship. In adjusted analyses, paid sick leave was associated with significant reductions in risk of overall mortality (hazard ratio [HR], 0.74 [95% CI, 0.61 to 0.9]; P = .003) and cancer mortality (HR, 0.74 [95% CI, 0.61 to 0.91]; P = .003). CONCLUSION In working cancer survivors, paid sick leave is associated with decreased care delays and lower overall and cancer-specific mortality risk, which may be due to maintained employment, household income, and health insurance coverage leading to improvements in treatment access, affordability, and overall survivorship care.
Enhanced financial assistance intervention for unmet essential needs: A prospective pilot study to improve timely cancer treatment completion.
Jiang, Shannon Jinxia, Johnson, Kimberly J., Yang, Joanna C. , Barnes, Justin M. , Johnson, Kimberly J., Chino, Fumiko

Mayo Clinic

Journal of Clinical Oncology | May 27, 2026 | Volume: 44 | Issue: 16_suppl | Pages: 11078-11078

10.1200/jco.2026.44.16_suppl.11078 Get It

11078 Background: Unmet essential needs, such as food, transportation, and housing insecurity, can create barriers to timely cancer treatment. Delayed or prolonged courses of definitive radiotherapy (RT) can compromise cancer outcomes like recurrence and survival. There are limited prospective data testing interventions to improve timely cancer treatment completion by meeting essential needs. Methods: We conducted a pragmatic single-arm pilot study testing an enhanced financial assistance intervention for unmet needs during RT. Eligibility criteria included adults with a cancer diagnosis and unmet social needs (via social risk screening and/or social worker evaluation) who were prescribed or undergoing a course of RT with > 10 fractions remaining. Participants received standard institutional assistance (e.g., limited support for travel/lodging with strict eligibility criteria) plus the enhanced assistance intervention, including needs assessments prior to and during RT and up to $2000/patient of tailored unconditional monetary transfer via gift cards for all essential needs identified. The primary outcome was delay-free completion of RT (DFC: completing all prescribed RT fractions and delaying < 5 fractions). The study was powered (power = 80%, 1-sided alpha = 0.2 for this pilot study) to detect a 10-percentage point increase in % DFC relative to a historic benchmark of 83% (based on similar patients from our institution), with required sample size of N = 33. Due to delays in gift card administration (on average ~2 weeks after consent), we also present per protocol analysis, limited to patients who had > 10 fractions remaining after first receiving financial assistance. Post-hoc analyses using generalized linear mixed models evaluated percentages of delayed fractions prior to and after an individual’s receipt of financial assistance. Results: 35 met inclusion criteria and were approached, 33/35 enrolled. Participants received median assistance of $1800 ($700-2000) and had a median of 27 RT fractions after consent (range: 12-35) and 17 (3-34) after receiving assistance. In the overall cohort, 1 patient did not complete RT and 2 patients had ≥5 delayed fractions, leading to 30/33 achieving DFC (90.9%, 80% CI = 83.9 – 100), significantly higher than the 83% benchmark. In the per protocol analysis, 27/28 achieved DFC (96.4%, 80% CI = 89.7–100, P = .037). Among the 27 patients who started RT prior to receiving assistance, mixed model analysis showed more delayed fractions prior to (7.1%) vs. after (3.0%) receiving assistance (OR 2.84, 95% CI = 1.43-5.80, P = .003). Conclusions: In this prospective pilot study, a tailored enhanced financial assistance intervention for unmet essential needs led to improved delay-free completion of RT over a historic benchmark. Further analysis on patient-reported quality of life and financial toxicity will be reported in the future. Clinical trial information: NCT06582849 .
Associations of State Mandatory Paid Sick Leave Policies With Cancer Outcomes in the United States
Kohut-Jackson, Abigail , Barnes, Justin M. , Chino, Fumiko , Zheng, Zhiyuan , Han, Xuesong, Johnson, Kimberly , Yabroff, K. Robin , Johnston, Kenton J. , Han, Xuesong , Zheng, Jason , Han, Xuesong , Johnson, Kimberly J , Yabroff, K Robin

Mayo Clinic

JCO Oncology Practice | April 10, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1200/op-25-00596 | PMID 41962062 Get It

PURPOSE Since 2012, several states have implemented mandatory paid sick leave (PSL) policies. PSL can provide patients time and income continuity to undergo screening and/or timely diagnostic workup for new cancer-related symptoms and complete lengthy and expensive cancer treatment courses. This study aimed to examine the association between mandatory PSL policies and cancer stage at diagnosis and overall survival (OS). METHODS Adults age 18-64 years diagnosed with cancer were identified from the Surveillance, Epidemiology, and End Results program registries between 2010 and 2019. Difference-in-differences (DID) analyses were used to compare absolute changes in stage I and stage IV diagnoses and 1-year OS before and after policy implementation in states that enacted mandatory PSL relative to states that did not enact such policies. RESULTS A total of 1,052,307 patients with cancer were included. In adjusted DID analyses, there were a 0.83 (95% CI = –1.49 to –0.16, P = .014) PP decrease in stage IV diagnoses and a 0.63 (95% CI = 0.10 to 1.17, P = .021) PP increase in 1-year OS associated with implementation of mandatory PSL policies. In exploratory analyses, males and individuals with lung cancer experienced the greatest shifts in policy-associated changes in stage at diagnosis and OS. CONCLUSION PSL policy implementation is associated with decreased late-stage diagnoses and improved OS in patients with cancer. Policies that improve opportunities to receive medical care may facilitate earlier cancer detection and ultimately contribute to better patient outcomes.
0797 Severe Obstructive Sleep Apnea Treated with Oral Appliance Therapy in Elderly Adults: A Cohort Study
Awadalla, Tanzeel Omer Elamin, Jagielski, Jack, Tripp, E. Gail, Johnson, Kimberly, Vadiyala, Mounika Reddy , Karnakoti, Snigdha , Herberts, Michelle , Westermeyer, Eliza Thompson, Giri, Subha , Escalante, Patricio , Tripp, Ellery, Arias, Pedro

Mayo Clinic

SLEEP | May 19, 2025 | Volume: 48 | Issue: Supplement_1 | Pages: A345-A345

10.1093/sleep/zsaf090.0797 Get It

Abstract Introduction Emerging evidence suggests that positive airway pressure (PAP) treatment for moderate-to-severe obstructive sleep apnea (OSA) in elderly patients does not improve daytime sleepiness, or quality of life outcomes, despite improving apnea-hypopnea index (AHI). While oral appliance therapy (OAT) is known to be an effective treatment for mild-to-moderate OSA, its efficacy in treatment of elderly patients with severe OSA is unknown. Methods Retrospective chart review of patients ≥ 65 years old with diagnosis of OSA, treated with OAT, who underwent subsequent follow-up sleep testing and clinical assessments, including Epworth Sleepiness Scale (ESS), a measure of daytime sleepiness. Results We studied 66 elderly patients with OSA (31 women, 35 men), including 58 with mild-to-moderate OSA (AHI &lt; 30) and 8 with severe OSA (AHI ≥ 30) treated with OAT. At baseline, patients with mild-to-moderate OSA had a median AHI of 11.6 compared to 41.3 in patients with severe OSA (p &lt; 0.0001). There was no difference in ESS score between patients with mild-to-moderate OSA (median ESS = 8; IQR = 4-12) and severe OSA (median ESS = 6; IQR = 3-9). Following their OSA diagnosis, OAT was offered due to PAP intolerance (n = 32), patient preference (n = 28), or as an alternative treatment option (n = 4). After initiation of OAT, 42 patients with mild-to-moderate and 7 with severe OSA underwent follow-up assessment with home sleep testing (n = 32), oximetry (n = 15), or polysomnography (n = 2). At follow-up assessment, ESS was decreased in patients with mild-to-moderate OSA (median ESS = 5; IQR = 3-8) and severe OSA (median ESS = 5; IQR = 3-7), indicating reduction in daytime sleepiness in response to OAT in both groups. Moreover, 50% of patients with mild-to-moderate OSA and 50% of severe OSA patients saw ≥ 50% reduction in AHI. Conclusion Our study findings suggest that treatment with OAT in mild-to-moderate and severe OSA is tolerable and effective in elderly patients who do not have contraindication for this treatment. OAT should be considered as an alternative treatment specifically for elderly adults with severe OSA not tolerating or improving with PAP therapy. Support (if any)
0291 Attending Physician Perceptions of Nightshift Work in the ICU: Results from a Large Tertiary Medical Center
Braksick, Sherri A. , Olson, Eric J. , Caples, Sean M., Johnson, Kimberly, Louis, Erik K. St. , Somers, Virend K.

Mayo Clinic

SLEEP | May 29, 2023 | Volume: 46 | Issue: Supplement_1 | Pages: A129-A129

10.1093/sleep/zsad077.0291 Get It

Abstract Introduction Nightshifts represent a substantial proportion of time dedicated to working in the inpatient setting, particularly among ICU staff. Our institution implemented a 24/7 in-person ICU attending model more than a decade ago. With practice growth and more than 200 ICU beds across disciplines, there are now at least 8 ICU attendings in-hospital all night. Yet, little is known about attending staff perceptions and desires about night work, so we began an exploratory analysis. Methods An online survey of 13 multiple-choice, slider scale, and open-ended questions were sent via email to critical care staff physicians of different disciplines within our institution. Results 69 out of 150 physicians completed the survey (46% response rate). Half were between 35 and 45 years old; 29% were age 45 to 55 years old. About half self-identified as a morningness chronotype. Most (84%) work 3- or 4-night shifts consecutively. Most viewed night shift work as having a negative influence on their quality of life (48% “somewhat negative” and 22% “very negative”) and on their health (51% “somewhat negative” and 24% “very negative”). Most would choose to work less nightshifts (37%) or none (29%). During nightshift assignments, about half (53%) self-report an average of 5 hours of sleep per 24-hour period; 18% self-report ≤ 4hours. Only 6% reported 7 or 8 hours of sleep. Mitigating strategies utilized during series of night shifts include use of caffeine (78%), naps (66%) and use of sleeping aids (21%). Outside of the nightshift series, more than half (56%) reported no sleep difficulties while 21% reported onset or maintenance insomnia. Conclusion At our large tertiary hospital employing an in-house nightshift model across multiple ICUs, most staff ICU physicians have a negative perception of night shift work on their quality of life and health. The majority of respondents would choose to work less or no night shifts. How self-reports of limited sleep (average 5 hours) per 24-hour period compare to objectively measured sleep duration in this population remains to be determined in the next phase of this study. Support (if any)
Pragmatic evaluation of events and benefits of lipid lowering in older adults ( PREVENTABLE ): Trial design and rationale
Joseph, Jacob , Pajewski, Nicholas M. , Dolor, Rowena J , Sellers, Mary Ann, Perdue, Letitia , Peeples, Sheronda R., Henrie, Adam M., Woolard, Nancy , Benziger, Catherine P. , Mixon, Amanda S. , VanWormer, Jeffrey J. , Chatterjee, Ranee , Newby, L. Kristin , Cicek, Mine , Williams, Neely , Decker, Jake E., Ou, Jiafu , Choudhary, Gaurav , Gazmuri, Raúl J. , Schmader, Kenneth E. , Vaughan, Camille P. , Ambrosius, Walter T. , Williamson, Jeff D. , Johnson, Kimberly S. , Espinoza, Sara , Markland, Alayne D. , Bazzano, Lydia , Benziger, Catherine P , Shapiro, Michael D , Kistler, Christine E , Gill, Thomas M , Newby, L Kristin , Cicek, Mine S , Ou, Jiafu , Gazmuri, Raúl J , Vaughan, Camille P , Supiano, Mark A , Shah, Raj C , Alexander, Karen P , Pajewski, Nicholas M , Espinoza, Sara , Jones, W. Schuyler , Orkaby, Ariela R. , Shapiro, Michael D. , Polonsky, Tamar S. , Chamberlain, Alanna M. , Forman, Daniel E. , Knowlton, Kirk U. , Gill, Thomas M. , Hammill, Bradley G. , Rubinstein, Jack , Roumie, Christianne L. , Effron, Mark B , Cooper‐DeHoff, Rhonda M. , Supiano, Mark A. , Shah, Raj C. , Whittle, Jeff , Hernandez, Adrian F. , Alexander, Karen P.

Mayo Clinic

Journal of the American Geriatrics Society | April 21, 2023 | Volume: 71 | Issue: 6 | Pages: 1701-1713

10.1111/jgs.18312 | PMID 37082807 Get It

Abstract Whether initiation of statins could increase survival free of dementia and disability in adults aged ≥75 years is unknown. PREVENTABLE, a double‐blind, placebo‐controlled randomized pragmatic clinical trial, will compare high‐intensity statin therapy (atorvastatin 40 mg) with placebo in 20,000 community‐dwelling adults aged ≥75 years without cardiovascular disease, disability, or dementia at baseline. Exclusion criteria include statin use in the prior year or for >5 years and inability to take a statin. Potential participants are identified using computable phenotypes derived from the electronic health record and local referrals from the community. Participants will undergo baseline cognitive testing, with physical testing and a blinded lipid panel if feasible. Cognitive testing and disability screening will be conducted annually. Multiple data sources will be queried for cardiovascular events, dementia, and disability; survival is site‐reported and supplemented by a National Death Index search. The primary outcome is survival free of new dementia or persisting disability. Co‐secondary outcomes are a composite of cardiovascular death, hospitalization for unstable angina or myocardial infarction, heart failure, stroke, or coronary revascularization; and a composite of mild cognitive impairment or dementia. Ancillary studies will offer mechanistic insights into the effects of statins on key outcomes. Biorepository samples are obtained and stored for future study. These results will inform the benefit of statins for increasing survival free of dementia and disability among older adults. This is a pioneering pragmatic study testing important questions with low participant burden to align with the needs of the growing population of older adults.
Histologic response to steroids in eosinophilic esophagitis is dependent on delivery compound
Schupack, Daniel , Johnson, Kimberly R. , Akambase, Joseph , Geno, Debra M., Lavey, Crystal, Lennon, Ryan J. , Snyder, Diana L. , Katzka, David A. , Alexander, Jeffrey A. , Schupack, D , Johnson, Kimberly , Akambase, Joseph A , Geno, Debra, Ravi, Karthik

Mayo Clinic

Diseases of the Esophagus | July 3, 2022 | Volume: 36 | Issue: 1 | Pages: No page available

10.1093/dote/doac040 | PMID 35780320 Get It

Summary Topical steroids are commonly used in treatment of eosinophilic esophagitis (EoE), but currently there is lack of data to clarify most effective regimen. We aimed to study the achievement of histologic remission using the same dose of budesonide in two different delivery formulations. Patients with established EoE treated with pharmacy compounded budesonide capsule or budesonide Rincinol gel (both 3 mg twice daily) were studied retrospectively. Those with pre-treatment and post-treatment histologic assessment were included with main endpoint being histologic remission. 103 patients (62 gel, 41 capsule) were included, with higher rate of histologic remission with gel (84 vs. 59%, P=0.004). A subset of patients in both groups had lack of steroid response (&lt;50% drop in eosinophils) (15% for gel, 32% for capsule). Formulation/delivery vehicle of steroid treatments to esophageal mucosa in EoE appears important for treatment efficacy, with budesonide gel having higher likelihood of histologic remission compared to budesonide capsules in our population. A truly steroid refractory group appears likely in our population. Larger, prospective studies may help clarify best regimen of topical steroids in EoE and may work to identify patients likely to benefit from alternative therapies.
System of Psychological Support Based on Positive Suggestions to the Critically Ill Using ICU Doulas
Karnatovskaia, Lioudmila V. , Schultz, Jason, Steele, Amanda J., Baker, Brittany A., Philbrick, Kemuel L. , Valle, Kathryn T. del , Johnson, Kimberly R. , Gajić, Ognjen, Varga, Katalin , Schultz, Jason M, Del Valle, Kathryn T, Del Valle, Kathryn T , Niven, Alexander S. , Baker, Brittany A., Gajic, Ognjen

Mayo Clinic

Critical Care Explorations | April 27, 2021 | Volume: 3 | Issue: 4 | Pages: e0403

10.1097/cce.0000000000000403 | PMID 33912833 Get It

Background: Surviving critical illness often creates a lasting psychological impact, including depression, anxiety, and post-traumatic stress. Memories of frightening and delusional experiences are the largest potentially modifiable risk factor, but currently, there is no proven intervention to improve these inciting factors. Psychological support based on positive suggestion is a psychotherapeutic approach that can be provided even to patients in altered cognitive states and is therefore a viable psychotherapy intervention throughout the ICU stay. Traditional ICU care team members have limited time and training to provide such psychological support to patients. Doulas are trained supportive companions who have been effectively used to provide patient advocacy and emotional support in other clinical settings and may address this need. Our aim was to train and implement a psychological support based on positive suggestion program for the critically ill using doulas, and measure acceptance of this intervention through stakeholder feedback. Methods: Doula training included three objectives: an introduction to ICU practice structure and policies; education about fundamental aspects of critical care conditions and procedures; and didactic and hands-on learning experiences in effective use of psychological support based on positive suggestion in the critically ill. Doulas were evaluated at the end of their training and during subsequent clinical activities using competency-based assessments as well as through survey-based questions and interviews with key stakeholders. Results: The ICU doulas performed psychological support based on positive suggestion on 43 critically ill patients in the ICU setting. Stakeholder feedback from nurses, patients, and patient families was positive. The majority (28/32) of surveyed bedside ICU nurses reported that the doulas’ involvement was helpful for both patients and nurses alike. All interviewed family members offered positive comments about the ICU doula presence and of the 40 patients who recalled the intervention 37 found it comforting. Conclusions: Our program successfully trained two doulas to work effectively in the ICU setting performing patient-centered psychological support based on positive suggestion interventions. Their training improved their skill sets and was reported as beneficial by patients, families, and critical care nursing. This training program offers a proof of concept that could be applied in other medical centers, bringing doulas more commonly into the ICU practice to help humanize the experience for patients, families, and medical teams.
797: Critical Care Staff Perspectives on ICU Diaries and Post-ICU Psychological Outcomes: A Survey Study
Johnson, Kimberly, Philbrick, Kemuel L. , Karnatovskaia, Lioudmila V.

Mayo Clinic

Critical Care Medicine | December 18, 2020 | Volume: 49 | Issue: 1 | Pages: 395-395

10.1097/01.ccm.0000729076.98325.63 Get It

TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR+ Metastatic Triple-Negative Breast Cancer
Abramson, Vandana G. , Sanders, Melinda E. , Mayer, Erica L. , Haddad, Tufia C. , Nanda, Rita , Poznak, Catherine Van , Storniolo, Anna Maria , Nangia, Julie R. , González-Ericsson, Paula I. , Johnson, Kimberly N., Chen, Sheau‐Chiann , Shyr, Yu , Arteaga, Carlos L. , Pietenpol, Jennifer A. , Abramson, Vandana G , Sanders, Melinda E , Mayer, Erica L , Gonzalez-Ericsson, Paula I , Abramson, Richard G , Chen, Sheau-Chiann , Wolff, Antonio C , Lehmann, Brian David , Sanchez, Violeta M. , Wolff, Antonio C.

Mayo Clinic

Clinical Cancer Research | December 10, 2019 | Volume: 26 | Issue: 9 | Pages: 2111-2123

10.1158/1078-0432.ccr-19-2170 | PMID 31822498 Get It

Abstract Purpose: Preclinical data demonstrating androgen receptor (AR)–positive (AR+) triple-negative breast cancer (TNBC) cells are sensitive to AR antagonists, and PI3K inhibition catalyzed an investigator-initiated, multi-institutional phase Ib/II study TBCRC032. The trial investigated the safety and efficacy of the AR-antagonist enzalutamide alone or in combination with the PI3K inhibitor taselisib in patients with metastatic AR+ (≥10%) breast cancer. Patients and Methods: Phase Ib patients [estrogen receptor positive (ER+) or TNBC] with AR+ breast cancer received 160 mg enzalutamide in combination with taselisib to determine dose-limiting toxicities and the maximum tolerated dose (MTD). Phase II TNBC patients were randomized to receive either enzalutamide alone or in combination with 4 mg taselisib until disease progression. Primary endpoint was clinical benefit rate (CBR) at 16 weeks. Results: The combination was tolerated, and the MTD was not reached. The adverse events were hyperglycemia and skin rash. Overall, CBR for evaluable patients receiving the combination was 35.7%, and median progression-free survival (PFS) was 3.4 months. Luminal AR (LAR) TNBC subtype patients trended toward better response compared with non-LAR (75.0% vs. 12.5%, P = 0.06), and increased PFS (4.6 vs. 2.0 months, P = 0.082). Genomic analyses revealed subtype-specific treatment response, and novel FGFR2 fusions and AR splice variants. Conclusions: The combination of enzalutamide and taselisib increased CBR in TNBC patients with AR+ tumors. Correlative analyses suggest AR protein expression alone is insufficient for identifying patients with AR-dependent tumors and knowledge of tumor LAR subtype and AR splice variants may identify patients more or less likely to benefit from AR antagonists.